Public Company News & Press Release Distribution

Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000

* Single-ascending-dose (SAD) study successfully demonstrated the safety, tolerability, and sustained release profile at least 3 months resulting from ALA-1000 injection in patients with opioid dependence. TAICHUNG, Taiwan, Jan. 12, 2022 /PRNewswire/ -- Alar Pharmaceuticals Inc. (Alar, TWSE:67...

2022-01-13 00:00 3024

Bon Natural Life Limited Received Initial Purchase Order for its Stachyose and Apple Extract based Personal Care Products

XIAN, China, Jan. 12, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has received an initial purchase order (the "Order") from ...

2022-01-12 21:30 4488

51job, Inc. Announces Receipt of a Proposal to Amend Merger Consideration for Going-Private Transaction

SHANGHAI, Jan. 12, 2022 /PRNewswire/ -- 51job, Inc. (Nasdaq: JOBS) ("51job" or the "Company"), a leading provider of integrated human resource services in China, announced today that its Board of Directors (the "Board") and the special committee of the Board (the "Special Committee") have receive...

2022-01-12 21:30 4874

Gracell Biotechnologies Unveils Innovation Center in U.S.

SUZHOU, China and PALO ALTO, Calif., Jan. 12, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...

2022-01-12 21:00 2156

I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the first patient had been dosed in itsChina phase...

2022-01-12 21:00 2168

Infosys: Revenue guidance for FY22 revised upwards to 19.5%-20.0%, powered by sequential growth of 7.0% in Q3

BENGALURU, India, Jan. 12, 2022 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong Q3 performance with sequential growth of 7.0% in a seasonally weak quarter and year-on-year growth of 21.5% in constan...

2022-01-12 20:53 10350

South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine

GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, today...

2022-01-12 20:43 3022

CICC's Dr. Huang Haizhou Receives the 19th Sun Yefang Economic Science Award

BEIJING, Jan. 12, 2022 /PRNewswire/ -- Dr. Huang Haizhou, Managing Director, a member of the Management Committee and Head of the Equity Business Department of CICC, together withPatrick Bolton, Professor of Economics and Finance at Columbia University, have received the 19th Sun Yefang Prize for...

2022-01-12 20:32 4756

OMD'S GUY MARKS NAMED CEO OF OMNICOM MEDIA GROUP EMEA

NEW YORK, Jan. 12, 2022 /PRNewswire/ -- Omnicom Media Group, the media services division ofOmnicom Group Inc. (NYSE: OMC) has named Guy Marks CEO of Omnicom Media Group EMEA. In his new role, Marks, previously leader of OMD EMEA, will oversee strategy, operations and the development and adoption ...

2022-01-12 20:00 3031

OMD'S GUY MARKS NAMED CEO OF OMNICOM MEDIA GROUP EMEA

CICC's Dr. Huang Haizhou Receives the 19th Sun Yefang Economic Science Award

BEIJING, Jan. 12, 2022 /PRNewswire/ -- Dr. Huang Haizhou, Managing Director, a member of the Management Committee and Head of the Equity Business Department of CICC, together withPatrick Bolton, Professor of Economics and Finance at Columbia University, have received the 19th Sun Yefang Prize for...

2022-01-12 19:51 4487

Yunji Expands and Further Develops High-end Private Label Health Food Brand Baiyueshan

HANGZHOU, China, Jan. 12, 2022 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, announced that its private label Baiyueshan ("the Brand") brand continues to be a megahit among customers. The wolfberry puree (the "Product") ...

2022-01-12 19:00 2670

Bionomics Limited participated in the H.C Wainwright BioConnect Conference

ADELAIDE, Australia, Jan. 12, 2022 /PRNewswire/ -- Bionomics Limited (ASX:BNO, NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company, participated in the H.C Wainwright BioConnect Conference that was held virtually fromJanuary 10-13, 2022. Dr Errol De Souza, Executive C...

2022-01-12 19:00 2704

Cloopen Group Holding Limited to Host Its Virtual Investor Conference on January 18, 2022

BEIJING, Jan. 12, 2022 /PRNewswire/ -- Cloopen Group Holding Limited (NYSE: RAAS) ("Cloopen" or the "Company"), a leading multi-capability cloud-based communications solution provider inChina, today announced that the Company will host its virtual investor conference onTuesday, January 18, 2022 a...

2022-01-12 18:09 3447

Cango Haoche's Display Function Drives Auto Sales

SHANGHAI, Jan. 12, 2022 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform inChina, today announced that "Cango Haoche," its B2B WeChat mini program providing automobile dealers with one-stop transaction, logistics, finance, and i...

2022-01-12 18:00 2911

Invitation to media and analyst briefing for Ericsson Q4 and full year 2021 report

STOCKHOLM, Jan. 12, 2022 /PRNewswire/ -- Ericsson's (NASDAQ: ERIC) financial report for the fourth quarter and full year of 2021 will be published at approximately7:00 AM CET on January 25, 2022. The company will issue a press release with the complete financial report attached, including tables...

2022-01-12 17:16 3040

Dada Group Awarded as the "Charity Star" by Shanghai

SHANGHAI, Jan. 12, 2022 /PRNewswire/ -- Dada Group (Nasdaq: DADA), China's leading local on-demand delivery and retail platform, is pleased to announce that the company was awarded "Charity Star" by Shanghai Municipal Government, which was also the only Internet and online economy enterprise sele...

2022-01-12 16:55 2543

Crunchfish announces 12th Gesture Interaction patent

STOCKHOLM, Jan. 12, 2022 /PRNewswire/ -- Crunchfish Gesture Interaction AB ("Crunchfish") has received an Intention to Grant from the European Patent Office (EPO) regarding gesture interaction with a physical or virtual display to type PIN codes or passwords in a unique way every time. The patent...

2022-01-12 15:54 2147

iQIYI's Super Sketch Show Helps Enable Development of China's Original Comedy Industry

BEIJING, Jan. 12, 2022 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, aired the season finale of its original variety showSuper Sketch Show (season one) on Jan. 7. The program brings China's comedy scene to the attention of the mainstream public and sets...

2022-01-12 15:34 3074

iQIYI's Super Sketch Show Helps Enable Development of China's Original Comedy Industry

Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC

SUZHOU, China, Jan. 12, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the TST001 US P...

2022-01-12 15:15 3754

Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma

SUZHOU, China and ROCKVILLE, Md., Jan. 11, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that Dr.Dajun Yang, the company's Chairman and CEO...

2022-01-12 10:19 2900